NO20004313D0 - FremgangsmÕte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer - Google Patents

FremgangsmÕte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer

Info

Publication number
NO20004313D0
NO20004313D0 NO20004313A NO20004313A NO20004313D0 NO 20004313 D0 NO20004313 D0 NO 20004313D0 NO 20004313 A NO20004313 A NO 20004313A NO 20004313 A NO20004313 A NO 20004313A NO 20004313 D0 NO20004313 D0 NO 20004313D0
Authority
NO
Norway
Prior art keywords
preparation
heterocyclic ring
ring systems
lipoxygenase inhibitors
varied
Prior art date
Application number
NO20004313A
Other languages
English (en)
Other versions
NO20004313L (no
Inventor
Timothy Norris
John Francis Lambert
Megan Elizabeth Hnatow
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20004313D0 publication Critical patent/NO20004313D0/no
Publication of NO20004313L publication Critical patent/NO20004313L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
NO20004313A 1999-08-31 2000-08-30 Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer NO20004313L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15161599P 1999-08-31 1999-08-31

Publications (2)

Publication Number Publication Date
NO20004313D0 true NO20004313D0 (no) 2000-08-30
NO20004313L NO20004313L (no) 2001-03-01

Family

ID=22539529

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004313A NO20004313L (no) 1999-08-31 2000-08-30 Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer

Country Status (33)

Country Link
US (1) US6346624B1 (no)
EP (1) EP1081143A1 (no)
JP (1) JP2001106682A (no)
KR (1) KR20010050256A (no)
CN (1) CN1286250A (no)
AP (1) AP2000001910A0 (no)
AU (1) AU5360300A (no)
BG (1) BG104731A (no)
BR (1) BR0003945A (no)
CA (1) CA2317097A1 (no)
CZ (1) CZ20003158A3 (no)
EA (1) EA200000801A1 (no)
EE (1) EE200000512A (no)
GT (1) GT200000142A (no)
HR (1) HRP20000564A2 (no)
HU (1) HUP0003439A3 (no)
ID (1) ID27129A (no)
IL (1) IL138087A0 (no)
IS (1) IS5603A (no)
MA (1) MA26751A1 (no)
NO (1) NO20004313L (no)
NZ (1) NZ506632A (no)
OA (1) OA11452A (no)
PA (1) PA8499701A1 (no)
PE (1) PE20010520A1 (no)
PL (1) PL342281A1 (no)
SG (1) SG87146A1 (no)
SK (1) SK12872000A3 (no)
SV (1) SV2002000159A (no)
TN (1) TNSN00177A1 (no)
TR (1) TR200002529A2 (no)
UY (1) UY26314A1 (no)
ZA (1) ZA200004435B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6669042B1 (en) * 2002-09-30 2003-12-30 Hewlett-Packard Development Company, L.P. Integrated positioning and locking device
US7674811B2 (en) 2006-03-14 2010-03-09 Ranbaxy Laboratories Limited 5-lipoxygenase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883106A (en) * 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
SK281577B6 (sk) 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze
US6063928A (en) * 1994-10-18 2000-05-16 Pfizer Inc 5-lipoxygenase inhibitors
US6239285B1 (en) * 1998-02-06 2001-05-29 Pfizer Inc Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems

Also Published As

Publication number Publication date
BR0003945A (pt) 2001-04-03
KR20010050256A (ko) 2001-06-15
EE200000512A (et) 2001-04-16
BG104731A (en) 2001-09-28
IS5603A (is) 2001-03-01
UY26314A1 (es) 2001-04-30
HUP0003439A3 (en) 2002-08-28
SK12872000A3 (sk) 2001-11-06
CA2317097A1 (en) 2001-02-28
CN1286250A (zh) 2001-03-07
SG87146A1 (en) 2002-03-19
ZA200004435B (en) 2002-02-28
OA11452A (en) 2003-12-08
PL342281A1 (en) 2001-03-12
TR200002529A2 (tr) 2001-04-20
HUP0003439A2 (hu) 2001-08-28
SV2002000159A (es) 2002-01-23
NZ506632A (en) 2002-02-01
AP2000001910A0 (en) 2000-09-30
TNSN00177A1 (fr) 2005-11-10
CZ20003158A3 (cs) 2001-09-12
EA200000801A1 (ru) 2001-04-23
HU0003439D0 (en) 2000-08-30
HRP20000564A2 (en) 2001-12-31
MA26751A1 (fr) 2004-12-20
PA8499701A1 (es) 2001-12-14
JP2001106682A (ja) 2001-04-17
AU5360300A (en) 2001-03-08
PE20010520A1 (es) 2001-04-28
ID27129A (id) 2001-03-01
NO20004313L (no) 2001-03-01
GT200000142A (es) 2002-02-19
US6346624B1 (en) 2002-02-12
IL138087A0 (en) 2001-10-31
EP1081143A1 (en) 2001-03-07

Similar Documents

Publication Publication Date Title
NO20014535L (no) Inhibitorer av IMPDH-enzym
NO20022510L (no) Fremgangsmåte for sammenkopling av rör
NO20026166L (no) Substituerte bicykliske derivater for behandling av abnormal cellevekst
NO20015547L (no) Fremgangsmåte for hemisyntese av forbindelser og nye forbindelser
NO20100667L (no) Fremgangsmate for fremstilling av mellomprodukter av benzoksazinderivater
NO20016405L (no) Fremgangsmåte for fremstilling av mikrokrystallinsk cellulose
NO20024256D0 (no) Fremgangsmåte for fremstilling av pyrimidonderivater med antifungal aktivitet
NO20022123D0 (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
NO20004312D0 (no) FremgangsmÕte for fremstilling av 5-lipoksygenase-inhibitorer med forskjellige heterocycliske ringsystemer
PT1206462E (pt) Compostos heterociclicos para inibicao da angiogenese
NO20020059D0 (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
NO20004313D0 (no) FremgangsmÕte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer
NO20013407L (no) Fremgangsmate for fremstilling av kinolinkarbaldehyd
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20013995D0 (no) Fremgangsmate for fremstilling av L-sorbose
HUP0202819A3 (en) Process for the preparation of thiazole derivatives and the new intermediates
NO20014383D0 (no) Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
NO20020073D0 (no) Fremgangsmåte ved fremstilling av trisykliske aminoalkoholderivater
HU0003438D0 (en) Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
NO20022157D0 (no) Fremgangsmåte for behandling av medikamentavhengighet
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
DK1041070T3 (da) Fremgangsmåde til fremstilling af cykliske thioamider
NO20014451D0 (no) Fremgangsmåte for fremstilling av tiazolidinderivater
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20022671D0 (no) Fremgangsmåte for fremstilling av tienopyrimidiner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application